Data and Documentation
Open Data Policy
FAQ
EN
DE
FR
Suchbegriff
Advanced search
Publication
Back to overview
Abacavir Induced T Cell Reactivity from Drug Naïve Individuals Shares Features of Allo-Immune Responses
Type of publication
Peer-reviewed
Publikationsform
Original article (peer-reviewed)
Publication date
2014
Author
Adam Jacqueline, Wuillemin Natascha, Watkins Stephan, Jamin Heidi, Eriksson Klara K., Villiger Peter, Fontana Stefano, Pichler Werner J., Yerly Daniel,
Project
Investigating the primary immune response against drugs in humans
Show all
Original article (peer-reviewed)
Journal
PLoS ONE
Volume (Issue)
9(4)
Page(s)
e95339 - e95339
Title of proceedings
PLoS ONE
DOI
10.1371/journal.pone.0095339
Open Access
URL
http://doi.org/10.1371/journal.pone.0095339
Type of Open Access
Publisher (Gold Open Access)
Abstract
Abacavir hypersensitivity is a severe hypersensitivity reaction which occurs exclusively in carriers of the HLA-B*57∶01 allele. In vitro culture of PBMC with abacavir results in the outgrowth of abacavir-reacting CD8+ T cells, which release IFNγ and are cytotoxic. How this immune response is induced and what is recognized by these T cells is still a matter of debate. We analyzed the conditions required to develop an abacavir-dependent T cell response in vitro. The abacavir reactivity was independent of co-stimulatory signals, as neither DC maturation nor release of inflammatory cytokines were observed upon abacavir exposure. Abacavir induced T cells arose in the absence of professional APC and stemmed from naïve and memory compartments. These features are reminiscent of allo-reactivity. Screening for allo-reactivity revealed that about 5% of generated T cell clones (n = 136) from three donors were allo-reactive exclusively to the related HLA-B*58∶01. The addition of peptides which can bind to the HLA-B*57∶01-abacavir complex and to HLA-B*58∶01 during the induction phase increased the proportion of HLA-B*58∶01 allo-reactive T cell clones from 5% to 42%. In conclusion, abacavir can alter the HLA-B*57∶01-peptide complex in a way that mimics an allo-allele (‘altered self-allele’) and create the potential for robust T cell responses.
-